ALB and retinal degeneration: Recently, it has been shown that albumin-modified IONPs can be used for prolonged drug release at the desired location in a rat model of retinal degeneration: the IONPs were detected by MRI up to 30 weeks in the injection area without changes in the retinal structure and function during suprachoroidal delivery [63].